Efavirenz
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 4796 publications
Association between initial antiretroviral therapy regimens and virological outcomes in HIV-infected individuals in Taizhou, Zhejiang Province, 2006-2025
Journal: Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi
Published: August 19, 2026
HIV care interruptions during the first year of antiretroviral therapy among adolescents and young adults living with HIV aged 15-24 years in Khayelitsha, South Africa.
Journal: Journal of acquired immune deficiency syndromes (1999)
Published: August 06, 2026
Factors Associated With Viral Load Suppression Among Adults on Dolutegravir and Efavirenz: A Cross-Sectional Study in Papua, Indonesia.
Journal: Journal of the International Association of Providers of AIDS Care
Published: July 17, 2026
Efavirenz Mitigates Dyslipidemia and Attenuates Ulcerative Colitis through Gut Microbiota Modulation.
Journal: ACS infectious diseases
Published: June 01, 2026
Virological impact of the programmatic dolutegravir transition at Mildmay Hospital Uganda: a before-and-after cohort study with subgroup and trajectory analysis, 2016-2023.
Journal: BMC infectious diseases
Published: April 29, 2026
Determination of free fraction (fu) of compounds by flux dialysis using the rapid equilibrium dialysis (RED) device: establishing empirical permeability for rapid estimation.
Journal: Xenobiotica; the fate of foreign compounds in biological systems
Published: April 28, 2026
Determination of free fraction (fu) of compounds by flux dialysis using the rapid equilibrium dialysis device: establishing empirical permeability for rapid estimation.
Journal: Xenobiotica; the fate of foreign compounds in biological systems
Published: April 28, 2026
Repurposing Antiretroviral Drugs for Urological Cancers: Differential Effects of Protease Inhibitors and NNRTIs on Prostate and Bladder Cancer Cells.
Journal: Cells
Published: April 25, 2026
Rezvilutamide combined with ADT in an HIV-positive patient with high-volume mHSPC on efavirenz-based antiretroviral therapy: a case report.
Journal: Frontiers in oncology
Published: April 24, 2026
Immune recovery following switch from EFV-based regimens to bictegravir/emtricitabine/tenofovir alafenamide in virologically suppressed immunological non-responders: a 144-week real-world cohort study in China.
Journal: Frontiers in immunology
Published: April 22, 2026
Efavirenz-Altered Gut-Microbiota, Tph1, and Systemic 5-HT Levels: Could They Affect Depression Mechanisms in Mice?
Journal: International journal of molecular sciences
Published: April 12, 2026
In-Depth Comparison of Fasted State Simulated Intestinal Fluid (FaSSIF) Versions via NMR Spectroscopy and Complementary Methods.
Journal: Molecular pharmaceutics
Published: April 10, 2026
Last Updated: 09/26/2026